+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-11-25Number of Pages: 131

Porcine Vaccine Market (Disease Indication - Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), and Porcine Circovirus Associated Disease (PCVAD); End User - Veterinary Hospitals and Hog/Pig Production Farms; Technology - Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and DNA Vaccines) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : North America Porcine Vaccine Market

4. Market Overview
     4.1. Introduction
            4.1.1. Disease Indication Definition
            4.1.2. Industry Evolution / Developments
     4.2.  Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.5. North America Porcine Vaccine Market Analysis and Forecasts, 2014–2024
     4.6. Porter’s Five Force Analysis
     4.7.Regulations of Veterinary Vaccine in North America

5. North America Porcine Vaccine Market Analysis and Forecasts, By Disease Indication 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Share Analysis Forecast By Disease Indication , 2014–2024
            5.4.1. Diarrhoea
            5.4.2. Swine Influenza
            5.4.3. Arthritis
            5.4.4. Bordatella Rhinitis
            5.4.5. Porcine Reproductive and Respiratory Virus (PRRSV)
            5.4.6. Porcine Circovirus Associated Disease (PCVAD)
            5.4.7. Others 
     5.5. Disease Indication  Comparison Matrix
     5.6. Market Attractiveness By Disease Indication 

6. North America Porcine Vaccine Market Analysis and Forecasts, By Technology
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Share Analysis Forecast By Technology , 2014–2024
            6.4.1. Inactivated Vaccines
            6.4.2. Live Attenuated Vaccines
            6.4.3. Toxoid Vaccines
            6.4.4. Recombinant Vaccines
            6.4.5. Conjugate Vaccines
            6.4.6. DNA Vaccines
     6.6. Market Attractiveness By Technology

7. North America Porcine Vaccine Market Analysis and Forecasts, By End-user 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Share Analysis Forecast By End-user , 2014–2024
            7.4.1. Veterinary Hospitals
            7.4.2. Hog/Pig Production Farm
     7.5. End-user  Comparison Matrix
     7.6. Market Attractiveness By End-user 

8. North America Porcine Vaccine Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value Share Analysis Forecast By Region
     8.4. Market Attractiveness By Country/Region

9. U.S. Porcine Vaccine Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Policies and Regulations
            9.1.3. Key Trends
     9.2. Market Value Share Analysis Forecast By Disease Indication , 2014–2024
            9.2.1. Diarrhoea
            9.2.2. Swine Influenza
            9.2.3. Arthritis
            9.2.4. Bordatella Rhinitis
            9.2.5. Porcine Reproductive and Respiratory Virus (PRRSV)
            9.2.6. Porcine Circovirus Associated Disease (PCVAD)
            9.2.7. Others 
     9.3. Market Value Share Analysis Forecast By Technology, 2014–2024
            9.3.1. Inactivated Vaccines
            9.3.2. Live Attenuated Vaccines
            9.3.3. Toxoid Vaccines
            9.3.4. Recombinant Vaccines
            9.3.5. Conjugate Vaccines
            9.3.6. DNA Vaccines
     9.4. Market Value Share Analysis Forecast By End-user, 2014–2024
            9.4.1. Veterinary Hospitals
            9.4.2. Hog/Pig Production Farm
     9.5. Market Value Share Analysis Forecast By Country , 2014–2024
     9.6. Market Attractiveness Analysis 
            9.6.1. By Disease Indication 
            9.6.2. By End-user 
            9.6.3. By Technology 
            9.6.4. By Country

10. Canada Porcine Vaccine Market Analysis and Forecast
     10.1.Introduction
            10.1.1. Key Findings
            10.1.2. Policies and Regulations
            10.1.3. Key Trends
     10.2.Market Value Share Analysis Forecast By Disease Indication , 2014–2024
            10.2.1. Diarrhoea
            10.2.2. Swine Influenza
            10.2.3. Arthritis
            10.2.4. Bordatella Rhinitis
            10.2.5. Porcine Reproductive and Respiratory Virus (PRRSV)
            10.2.6. Porcine Circovirus Associated Disease (PCVAD)
            10.2.7. Others 
     10.3.Market Value Share Analysis Forecast By Technology , 2014–2024
            10.3.1. Inactivated Vaccines
            10.3.2. Live Attenuated Vaccines
            10.3.3. Toxoid Vaccines
            10.3.4. Recombinant Vaccines
            10.3.5. Conjugate Vaccines
            10.3.6. DNA Vaccines
     10.4.Market Value Share Analysis Forecast By End-user , 2014–2024
            10.4.1. Veterinary Hospitals
            10.4.2. Hog/Pig Production Farm
     10.5.Market Value Share Analysis Forecast By Country , 2014–2024
     10.6.Market Attractiveness Analysis 
            10.6.1. By Disease Indication 
            10.6.2. By End-user 
            10.6.3. By Technology 
            10.6.4. By Country

11. Competition Landscape
     11.1.Market Player – Competition Matrix
     11.2.Market Share Analysis By Company (2016) Estimated
     11.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            11.3.1. Bayer AG.
                       11.3.1.1. Overview
                       11.3.1.2. Financials
                       11.3.1.3. Recent Developments
                       11.3.1.4. Strategy
            11.3.2. Bimeda Animal Health 
                       11.3.2.1. Overview
                       11.3.2.2. Financials
                       11.3.2.3. Recent Developments
                       11.3.2.4. Strategy
            11.3.3. Boehringer Ingelheim GmbH 
                       11.3.3.1. Overview
                       11.3.3.2. Financials
                       11.3.3.3. Recent Developments
                       11.3.3.4. Strategy
            11.3.4. Ceva Santé Animale
                       11.3.4.1. Overview
                       11.3.4.2. Financials
                       11.3.4.3. Recent Developments
                       11.3.4.4. Strategy 
            11.3.5. Elanco (Eli Lilly and Company)
                       11.3.5.1. Overview
                       11.3.5.2. Financials
                       11.3.5.3. Recent Developments
                       11.3.5.4. Strategy
            11.3.6. Merck & Co., Inc.
                       11.3.6.1. Overview
                       11.3.6.2. Financials
                       11.3.6.3. Recent Developments
                       11.3.6.4. Strategy 
            11.3.7. Merial (Sanofi)
                       11.3.7.1. Overview
                       11.3.7.2. Financials
                       11.3.7.3. Recent Developments
                       11.3.7.4. Strategy
            11.3.8. Vetoquinol
                       11.3.8.1. Overview
                       11.3.8.2. Financials
                       11.3.8.3. Recent Developments
                       11.3.8.4. Strategy
            11.3.9. Zoetis, Inc.
                       11.3.9.1. Overview
                       11.3.9.2. Financials
                       11.3.9.3. Recent Developments
                       11.3.9.4. Strategy
            11.3.10. Others

List of Figures

FIG 1: North America Porcine Vaccine Market Size (US$ Mn) Forecast, 2014–2024
FIG 2: Market Value Share, by Disease Indication
FIG 3: Market Value Share, by Technology
FIG 4: Market Value Share, by Country
FIG 5: Market Value Share, by End-user
FIG 6: North America Porcine vaccine Market Value Share Analysis, by Disease Indication, 2016 and 2024
FIG 7: North America Diarrhea Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG 8: North America Swine Influenza Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG 9: North America Arthritis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG 10: North America Bordatella Rhinitis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG 11: North America PRRSV Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG 12: North America PCVAD Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG 13: North America Other Disease Indication Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
FIG 14: North America Porcine vaccine Market Attractiveness Analysis, by Disease Indication, 2016–2024
FIG 15: North America Porcine vaccine Market Value Share Analysis, by Technology, 2016 and 2024
FIG 16: North America Inactivated vaccine Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 17: North America Live Attenuated vaccine Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 18: North America Toxoid vaccine Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 19: North America Recombinant vaccine Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 20: North America Conjugate vaccine Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 21: North America DNA vaccine Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 22: North America Porcine vaccine Market Attractiveness Analysis, by Technology, 2016–2024
FIG 23: North America Porcine vaccine Market Value Share Analysis, By End-user, 2016 and 2024
FIG 24: North America Veterinary Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2014–2024
FIG 25: North America Hog/Pig Production Farms Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 
2014–2024
FIG 26: North America Porcine vaccine Market Attractiveness Analysis, by End-user, 2016–2024
FIG 27: North America Porcine vaccine Market Value Share Analysis, by Country, 2016 and 2024
FIG 28: North America Porcine Vaccine Market Attractiveness Analysis, by Country, 2016–2024
FIG 29: U.S. Porcine Vaccine Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
FIG 30: U.S. Porcine vaccine Market Value Share Analysis, by Disease Indication, 2016 and 2024
FIG 31: U.S. Porcine vaccine Market Value Share Analysis, by Technology, 2016 and 2024
FIG 32: U.S. Porcine vaccine Market Value Share Analysis, by End-user, 2016 and 2024
FIG 33: U.S. Market Attractiveness Analysis, by Disease Indication, 2016–2024
FIG 34: U.S. Market Attractiveness Analysis, by Technology, 2016–2024
FIG 35: U.S. Market Attractiveness Analysis, by End-user, 2016–2024
FIG 36: Canada Porcine Vaccine Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2014–2024
FIG 37: Canada Porcine Vaccine Market Value Share Analysis, by Disease Indication, 2016 and 2024
FIG 38: Canada Porcine Vaccine Market Value Share Analysis, by Technology, 2016 and 2024
FIG 39: Canada Porcine Vaccine Market Value Share Analysis, by End-user, 2016 and 2024
FIG 40: Canada Porcine Vaccine Market Attractiveness Analysis, by Disease Indication, 2016–2024
FIG 41: Canada Porcine Vaccine Market Attractiveness Analysis, by Technology, 2016–2024
FIG 42: Canada Porcine Vaccine Market Attractiveness Analysis, by End-user, 2016–2024
FIG 43: North America Porcine Vaccine Market Share Analysis, by Company (2015)

List of Tables

Table 1: North America Porcine vaccine Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 2: North America Porcine vaccine Market Size (US$ Mn) Forecast, by Technology, 2014–2024
Table 3: North America Porcine vaccine Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 4: North America Porcine vaccine Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 5: U.S. Porcine vaccine Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 6: U.S. Porcine vaccine Market Size (US$ Mn) Forecast, by Technology, 2014–2024
Table 7: U.S. Porcine vaccine Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 8: Canada Porcine Vaccine Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 9: Canada Porcine Vaccine Market Size (US$ Mn) Forecast, by Technology, 2014–2024
Table 10 Canada Porcine Vaccine Market Size (US$ Mn) Forecast, by End-user, 2014–2024

 


 
 
Back To Top